Lobbying Activity Report

2301-38872

Organization: Novartis Pharmaceuticals Canada Inc.
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 10154-2301-38
Lobbying Activity date: 2025-01-06
Arranged a meeting: No
Posted date: 2025-01-15

In-house lobbyists who participated in the lobbying activity: Jordan Roumieu
Senior Public Office Holders who were lobbied in this activity: Rick Glumac, MLA for Port Moody-Burquitlam
Member(s) of the BC Legislative Assembly
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussions with BC government officials/organizations and elected representatives to obtain public reimbursement of Novartis' innovative treatments for BC citizens that require access to these treatments, through various BC government funded programs such as Pharmacare, Health Authorities, BC Cancer Agency, etc. And, to encourage the BC government to recognize the importance of Novartis investments in Research and Development.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Health, Hospitals
 
Senior officer who filed this Lobbying Activity Report: Mark Vineis
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Western Canada Wilderness Committee
Date Modified: